Lord, Abbett & Co. LLC United Therapeutics Corp Transaction History
Lord, Abbett & Co. LLC
- $30.6 Billion
- Q2 2024
A detailed history of Lord, Abbett & Co. LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 155,525 shares of UTHR stock, worth $58.2 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
155,525Holding current value
$58.2 Million% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
641Shares Held
45.2MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$2.05 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.65 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.23 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.07 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$858 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $17B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...